CW July 2006Issue Number 7 July 2006 ISSN 10593802 Switch to Letrozole Improves Breast Cancer Survival After Taking TamoxifenPost-menopausal women with breast cancer who switch from tamoxifen (Nolvadex) to letrozole (Femara) show dramatic reduction in risk of recurrence, distant metastasis, and better survival.
Go to Previous Page Go to Next Page Source & Additional Reading Presented at the American Society of Clinical Oncology Annual Meeting in Atlanta. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |